Ad

IBT – IBEX Technologies Inc

Compliant

★☆☆☆☆

IBEX Technologies Inc is Shariah compliant. The company’s financials pass just one standard and fail in the other four.

$10,464,948

Market cap

91.28%

Revenue Growth

-

Analysts' Rating

Ad
N/A

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

IBEX Technologies Inc. manufactures and markets proteins for biomedical use through its wholly owned subsidiary, IBEX Pharmaceuticals Inc. IBEX Pharmaceuticals Inc. also manufactures and markets a series of arthritis assays, which are used in osteoarthritis research. The Company’s subsidiaries also include Technologies IBEX R&D Inc., IBEX Technologies Corporation and Bio-Research Products Inc. (BRP).

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses